December 1, 2022
The Japanese health ministry said on November 30 that the expiration date of some lots of AstraZeneca’s COVID-19 antibody cocktail therapy Evusheld (tixagevimab/cilgavimab) was extended for six months. Subject to the extension are lots with the expiration date lasting through...read more